{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:04:01Z","timestamp":1793048641054,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41431-025-01808-x","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T09:36:13Z","timestamp":1742204173000},"page":"810-813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pathogenic germline variants in patients with early-onset colorectal cancer according to phenotype"],"prefix":"10.1038","volume":"33","author":[{"given":"Antoine","family":"Dardenne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7279-5549","authenticated-orcid":false,"given":"Marion","family":"Dhooge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Basset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9835-2156","authenticated-orcid":false,"given":"Albain","family":"Chansavang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Metras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solenne","family":"Farelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Netter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Coulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1003-1997","authenticated-orcid":false,"given":"Patrick R.","family":"Benusiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"1808_CR1","unstructured":"NCCN Guidelines Version 3. 2024 Genetic\/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric [Internet]. 2024 [cited 2024 Nov 6]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_ceg.pdf."},{"key":"1808_CR2","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.dld.2024.01.208","volume":"56","author":"T Lecomte","year":"2024","unstructured":"Lecomte T, Tougeron D, Chautard R, Bressand D, Bibeau F, Blanc B, et al. Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR). Dig Liver Dis. 2024;56:756\u201369.","journal-title":"Dig Liver Dis"},{"key":"1808_CR3","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1093\/annonc\/mdz233","volume":"30","author":"N Stjepanovic","year":"2019","unstructured":"Stjepanovic N, Moreira L, Carneiro F, Balaguer F, Cervantes A, Balma\u00f1a J, et al. Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. \u2020 Ann Oncol 2019;30:1558\u201371.","journal-title":"\u2020 Ann Oncol"},{"key":"1808_CR4","doi-asserted-by":"publisher","first-page":"e2200517","DOI":"10.1200\/PO.22.00517","volume":"6","author":"SE Coughlin","year":"2022","unstructured":"Coughlin SE, Heald B, Clark DF, Nielsen SM, Hatchell KE, Esplin ED, et al. Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer. JCO Precis Oncol. 2022;6:e2200517.","journal-title":"JCO Precis Oncol"},{"key":"1808_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/DCR.0000000000002347","volume":"66","author":"YN You","year":"2023","unstructured":"You YN, Moskowitz JB, Chang GJ, Mork ME, Rodriguez-Bigas MA, Bednarski BK, et al. Germline Cancer Risk Profiles of Patients With Young-Onset Colorectal Cancer: Findings From a Prospective Universal Germline Testing and Telegenetics Program. Dis Colon Rectum. 2023;66:531.","journal-title":"Dis Colon Rectum"},{"key":"1808_CR6","doi-asserted-by":"publisher","first-page":"104080","DOI":"10.1016\/j.ejmg.2020.104080","volume":"63","author":"M Dhooge","year":"2020","unstructured":"Dhooge M, Baert-Desurmont S, Corsini C, Caron O, Andrieu N, Berthet P, et al. National recommendations of the French Genetics and Cancer Group - Unicancer on the modalities of multi-genes panel analyses in hereditary predispositions to tumors of the digestive tract. Eur J Med Genet. 2020;63:104080.","journal-title":"Eur J Med Genet"},{"key":"1808_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1808_CR8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1053\/j.gastro.2017.11.004","volume":"154","author":"EM Stoffel","year":"2018","unstructured":"Stoffel EM, Koeppe E, Everett J, Ulintz P, Kiel M, Osborne J, et al. Germline Genetic Features of Young Individuals With Colorectal Cancer. Gastroenterology. 2018;154:897\u2013905.e1.","journal-title":"Gastroenterology"},{"key":"1808_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1001\/jamaoncol.2015.0197","volume":"1","author":"MB Yurgelun","year":"2015","unstructured":"Yurgelun MB, Masciari S, Joshi VA, Mercado RC, Lindor NM, Gallinger S, et al. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. JAMA Oncol. 2015;1:214\u201321.","journal-title":"JAMA Oncol"},{"key":"1808_CR10","doi-asserted-by":"crossref","unstructured":"Ranganathan M, Sacca RE, Trottier M, Maio A, Kemel Y, Salo-Mullen E, et al. Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch Syndrome. JCO Precis Oncol. 2023;e2200675.","DOI":"10.1200\/PO.22.00675"},{"key":"1808_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jamaoncol.2016.5194","volume":"3","author":"R Pearlman","year":"2017","unstructured":"Pearlman R, Frankel WL, Swanson B, Zhao W, Yilmaz A, Miller K, et al. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer. JAMA Oncol. 2017;3:464\u201371.","journal-title":"JAMA Oncol"},{"key":"1808_CR12","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1200\/JCO.24.00662","volume":"42","author":"N Tung","year":"2024","unstructured":"Tung N, Ricker C, Messersmith H, Balma\u00f1a J, Domchek S, Stoffel EM, et al. Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline. J Clin Oncol. 2024;42:2599\u2013615.","journal-title":"J Clin Oncol"},{"key":"1808_CR13","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1136\/jmg-2022-108984","volume":"60","author":"L Valle","year":"2023","unstructured":"Valle L, Katz LH, Latchford A, Mur P, Moreno V, Frayling IM, et al. Position statement of the International Society for Gastrointestinal Hereditary Tumours (InSiGHT) on APC I1307K and cancer risk. J Med Genet. 2023;60:1035\u201343.","journal-title":"J Med Genet"},{"key":"1808_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cancergen.2023.10.002","volume":"278\u2013279","author":"E Mundt","year":"2023","unstructured":"Mundt E, Mabey B, Rainville I, Ricker C, Singh N, Gardiner A, et al. Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants. Cancer Genet. 2023;278\u2013279:84\u201390.","journal-title":"Cancer Genet"},{"key":"1808_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jmoldx.2020.12.003","volume":"23","author":"BJ Pope","year":"2021","unstructured":"Pope BJ, Clendenning M, Rosty C, Mahmood K, Georgeson P, Joo JE, et al. Germline and Tumor Sequencing as a Diagnostic Tool To Resolve Suspected Lynch Syndrome. J Mol Diagn JMD. 2021;23:358\u201371.","journal-title":"J Mol Diagn JMD"},{"key":"1808_CR16","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1053\/j.gastro.2022.08.041","volume":"163","author":"IB Te Paske","year":"2022","unstructured":"Te Paske IB, Mensenkamp AR, Neveling K, Baert-Desurmont S, Claes KBM, de Leeneer K, et al. Noncoding Aberrations in Mismatch Repair Genes Underlie a Substantial Part of the Missing Heritability in Lynch Syndrome. Gastroenterology. 2022;163:1691\u201394.e7.","journal-title":"Gastroenterology"},{"key":"1808_CR17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41431-023-01494-7","volume":"32","author":"PM Bj\u00f8rnstad","year":"2024","unstructured":"Bj\u00f8rnstad PM, Aal\u00f8kken R, \u00c5sheim J, Sundaram AYM, Felde CN, \u00d8stby GH, et al. A 39 kb structural variant causing Lynch Syndrome detected by optical genome mapping and nanopore sequencing. Eur J Hum Genet. 2024;32:513\u201320.","journal-title":"Eur J Hum Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01808-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01808-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01808-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T05:39:55Z","timestamp":1750657195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01808-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1808"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01808-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5002627\/v1","asserted-by":"object"}]},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.R.B. has received honoraria from AstraZeneca, M.S.D. and B.M.S., and funding support from Astrazeneca (unrelated to the present study).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"In France, ethics committee approval is not required for retrospective studies such as this one. However, and in accordance with French law, all participants were sent an information note with the possibility to opt out.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}